China must co-work better with COVID origin test: WHO Kumar Jeetendra | July 15, 2021 China must co-operate better in the probe into the origins of the coronavirus pandemic, the first cases of which were seen in Wuhan in December 2019, the head of World Health Organization said on Thursday. “We hope there will be better co-operation to get to the bottom of what happened,” Tedros Adhanom Ghebreyesus told a …
HIV ‘significant’ risk factor for severe COVID: WHO Kumar Jeetendra | July 15, 2021 HIV is a “significant” risk factor for severe COVID-19, the World Health Organization said in research published on Thursday that showed a major increase in deaths among patients who have the virus that causes AIDS and are also hospitalised with COVID-19. There are more than 37 million people known to be living with HIV globally, …
Over 40.31 crore COVID-19 immunization dosages so far gave to states/UTs: Center Kumar Jeetendra | July 15, 2021 Over 40.31 crore COVID-19 vaccine doses have so far been provided to states/UTs in the country and more than 1.92 crore balance and unutilised jabs are still available with them and private hospitals, the health ministry said on Thursday. In a statement, the ministry said 83,85,790 more doses are in the pipeline. “More than 40.31 …
Analysts study the role of subnuclear NSrp70 in T cell-intervened adaptive immunity Kumar Jeetendra | July 15, 2021 T cell are part of the body’s immune response. The way proteins are spliced in their development and maturation determines how T cells can recognize different pathogens and mount defense against them. Scientists from Korea now highlight the role of NSrp70 in regulating maturation. This protein was previously found in T cells subnuclear space and …
Blood thinner may lessen death risk in decently sick COVID-19 patients: Study Kumar Jeetendra | July 14, 2021 Administering a full dose of a standard blood thinner early to moderately ill hospitalised patients with COVID-19 could halt the formation of blood clots and reduce the risk of severe disease and death, according to a study. COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly in the lungs, and …
Sputnik V second dose deficiency to defer India’s full rollout: Dr Reddy’s Kumar Jeetendra | July 12, 2021 India’s full rollout of the Sputnik V COVID-19 vaccine will have to be put on hold until the Russian producer provides equal quantities of its two differing doses, Dr. Reddy’s Laboratories Ltd said on Monday. Dr. Reddy’s had received about 3 million first doses by June 1 and about 360,000 doses of the second by …
WHO board of trustees calls for gene editing tools to be imparted to more poorer countries Kumar Jeetendra | July 12, 2021 A World Health Organization (WHO) committee said on Monday that human genome editing technologies to treat serious disease should be shared more generously, to allow poorer nations to benefit from the highly dynamic scientific field. “WHO should work with others to encourage relevant patent holders to help ensure equitable access to human genome editing interventions,” …
MRI screening and designated biopsies could diminish overdiagnoses of prostate malignant growth Kumar Jeetendra | July 10, 2021 Many countries do not have nationwide prostate-cancer screening. Current methods lead to overdiagnoses, unnecessary biopsies, and unnecessary biopsies. Researchers at Karolinska Institutet, Sweden, have published a new study in The New England Journal of Medicine. It shows that targeted biopsies and magnetic resonance imaging (MRI), could reduce overdiagnoses by up to half. These results were …
No instance of SARS-CoV-2’s Lambda variation found in India yet: Govt Kumar Jeetendra | July 9, 2021 The government Friday asserted that no case of the Lambda variant of SARS-CoV-2 has been found in India so far. Responding to a question at a press briefing, joint secretary in the health ministry, Lav Agarwal, said Indian SARS-CoV-2 Genomics Consortium (INSACOG) is closely monitoring the variant. “Lambda was the seventh variant of interest identified …
Coronavirus in all probability of natural not spilled from lab: Study Kumar Jeetendra | July 9, 2021 The SARS-CoV-2 virus, which causes COVID-19, most likely spread from an animal source to humans, and did not leak from a laboratory in Wuhan, China, according to a review of existing scientific evidence by a global team of scientists. The yet-to-be published study, posted on the pre-print server Zenodo on July 7, noted that while …
PolyNovo’s NovoSorb® BTM technology featured in a new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions Kumar Jeetendra | July 7, 2021 Melbourne, Australia – 30 June, 2021 – A new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions, uncovers the stories of innovation using nature’s building blocks to change the world every day through biotechnology. This exploratory online video series uncovers the powerful stories of innovation in biotechnology and includes …
Study recognizes specific immune cells that shape inhibitory neurons to control mind wiring Kumar Jeetendra | July 7, 2021 Every second our brains are exposed to a variety of signals, from the barking of a puppy to raindrops hitting the windows, and everything in between. Most of the time we ignore insignificant cues like the buzzing of a fly or the gentle rustle of leaves in a tree. We pay attention to the more …
